ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

18,389Medicare Part D Prescriptions Filled, Including Refills

Rank: 46 out of 890

$962K Total Retail Price of All Prescriptions

Rank: 53 out of 890

524 Patients Receiving at Least One Drug in Part D
86%Patients 65 Years and Older
57% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Louisiana
Lower avg

Schedule Two
Controlled Substances

3% of this provider’s 524 patients filled at least one prescription for a schedule two drug, compared to an average of 2%.

Schedule Three
Controlled Substances

18% of this provider’s 524 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Risky Drugs to Seniors

2% of this provider’s 15,851 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$52 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

35 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Louisiana
LISINOPRIL 774 721 1 4
LOVASTATIN 551 530 2 46
LEVOTHYROXINE SODIUM 538 474 3 2
AMLODIPINE BESYLATE 487 462 4 1
HYDROCODONE-ACETAMINOPHEN 483 451 S3 5 3
FUROSEMIDE 467 432 6 7
OMEPRAZOLE 399 285 7 8
CITALOPRAM HBR 379 319 8 20
SIMVASTATIN 366 299 9 5
METFORMIN HCL 363 329 10 6
GABAPENTIN 343 281 11 12
HYDROCHLOROTHIAZIDE 332 288 12 9
DOXAZOSIN MESYLATE 288 283 13 70
POTASSIUM CHLORIDE 275 261 14 11
ALENDRONATE SODIUM 260 260 15 38
MELOXICAM 253 226 16 18
METOPROLOL TARTRATE 246 207 17 15
NAMENDA 245 229 18 36
DONEPEZIL HCL 224 201 19 30
CRESTOR 224 219 19 25
PRAVASTATIN SODIUM 211 186 21 10
TRIAMTERENE-HCTZ 204 194 22 61
PAROXETINE HCL 190 65 23 68
NEXIUM 189 159 24 14
FLUTICASONE PROPIONATE 184 144 25 39
ATENOLOL 177 173 26 23
GLIPIZIDE 168 136 27 62
WARFARIN SODIUM 164 151 28 24
ALLOPURINOL 147 143 29 31
RISPERIDONE 146 67 30 78
TAMSULOSIN HCL 146 115 30 32
FLUOXETINE HCL 145 139 32 63
METOPROLOL SUCCINATE 136 136 33 17
TRAMADOL HCL 136 115 33 16
CLOPIDOGREL 132 132 35 28
LOSARTAN POTASSIUM 126 117 36 29
NIFEDIPINE ER 124 96 37 75
FENOFIBRATE 114 109 38 74
ATORVASTATIN CALCIUM 114 99 38 13
JANUVIA 109 97 40 59
KLOR-CON 10 109 87 40 189
BUMETANIDE 107 91 42 134
MECLIZINE HCL 107 107 42 97
PANTOPRAZOLE SODIUM 105 102 44 34
ZOLPIDEM TARTRATE 104 81 45 19
BACLOFEN 103 84 46 161
RAMIPRIL 98 98 47 80
PLAVIX 96 96 48 42
COLCRYS 95 85 49 150
PROAIR HFA 92 86 50 55
PREDNISONE 88 83 51 47
ADVAIR DISKUS 87 76 52 52
BENAZEPRIL HCL 86 86 53 44
LISINOPRIL-HYDROCHLOROTHIAZIDE 85 77 54 21
CARVEDILOL 85 65 54 22
MIRTAZAPINE 84 82 56 82
CYCLOBENZAPRINE HCL 81 77 R 57 64
POLYETHYLENE GLYCOL 3350 80 65 58 67
COMBIVENT 79 69 59 144
TRAZODONE HCL 77 65 60 40
KLOR-CON M10 76 65 61 165
SERTRALINE HCL 75 42 62 26
ENALAPRIL MALEATE 71 61 63 56
AZITHROMYCIN 71 67 63 37
ACTOS 70 70 65 88
DIOVAN 69 64 66 33
QUETIAPINE FUMARATE 66 60 67 73
ISOSORBIDE MONONITRATE ER 66 57 67 60
ABILIFY 65 50 69 172
GLYBURIDE 64 64 R 70 83
DILTIAZEM 24HR CD 63 52 71 156
NIFEDIAC CC 62 42 72 343
LEVOFLOXACIN 59 56 73 107
DIVALPROEX SODIUM 57 30 74 126
DIOVAN HCT 57 48 74 48
QUINAPRIL HCL 55 55 76 116
GLIMEPIRIDE 55 46 76 27
CYMBALTA 54 45 78 45
SPIRIVA 54 50 78 66
HYDRALAZINE HCL 54 52 78 100
BISOPROLOL-HYDROCHLOROTHIAZIDE 53 53 81 122
PROPRANOLOL HCL 52 38 82 141
CARBIDOPA-LEVODOPA 52 52 82 136
HALOPERIDOL 52 0 82 286
CARBAMAZEPINE 51 24 85 238
PHENYTOIN SODIUM EXTENDED 51 16 85 111
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 13, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.